IMMUNOTHERAPY FOR HER2 POSITIVE BREAST CANCER

被引：0
|
作者：
Vaidya, T. R. [1 ]
Ait-Oudhia, S. [1 ]
机构：
[1] Univ Florida, Coll Pharm, Orlando, FL USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2017年 / 101卷 / S1期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PI-003
引用
收藏
页码：S20 / S20
页数：1
相关论文
共 50 条
  • [1] HER2 positive breast cancer
    Gianni, Luca
    Bianchini, Giampaolo
    CANCER RESEARCH, 2023, 83 (05)
  • [2] Her2 positive breast cancer: practices
    Campone, Mario
    Berton-Rigaud, Dominique
    Bourbouloux, Emmanuelle
    Sophie, Sadot
    Zanetti, Alain
    Frenel, Jean-Sebastien
    BULLETIN DU CANCER, 2011, 98 (02) : 154 - 163
  • [3] Delayed breast cancer surgery in HER2 positive breast cancer
    Hur, Ho
    Le, Amy
    Chang, Helena R.
    CANCER RESEARCH, 2020, 80 (04)
  • [4] HER2 status in breast cancer patients: A comparison between borderline positive HER2 and strongly positive HER2 tumors
    Huszno, J.
    Nowara, E.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S137 - S137
  • [5] Immunotherapy for HER-2 positive breast cancer
    Yang, Tingting
    Kang, Lihua
    Li, Dan
    Song, Yanqiu
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [6] Personalized medicine for HER2 positive breast cancer
    Tamura, Kenji
    ANNALS OF ONCOLOGY, 2016, 27
  • [7] Characterization of HER2 positive breast cancer in Tunisia
    Yaiche, R.
    Houcine, Y.
    Saidi, E.
    Saadallah, F.
    Kamoun, S.
    Meddeb, K.
    Driss, M.
    VIRCHOWS ARCHIV, 2024, 485 : S210 - S210
  • [8] Delayed chemotherapy in HER2 positive breast cancer
    Hur, Ho
    Le, Amy
    Chang, Helena R.
    CANCER RESEARCH, 2020, 80 (04)
  • [9] Treatment of HER2 positive breast cancer patients
    Matos, Erika
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2012, 81 (03): : 236 - 245
  • [10] HER2 POSITIVE BREAST CANCER - BIOLOGY AND RESISTANCE
    Penault-Llorca, Frederique
    BREAST, 2019, 48 : S31 - S31
12345